Why is GPT Healthcare falling/rising?

As of 15-Jul, GPT Healthcare Ltd's stock price is currently at 176.40, reflecting an increase of 4.6, or 2.68%. The stock has shown strong performance recently, with a 1-week return of 11.50% and a 1-month return of 17.64%, significantly outperforming the Sensex, which has declined by 1.36% over the same week. Today's trading indicates that the stock reached an intraday high of Rs 179.7, and it is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. However, there has been a decline in investor participation, with delivery volume dropping by 10.92% compared to the 5-day average. The company maintains a high management efficiency with a return on capital employed (ROCE) of 28.30% and a low debt-to-equity ratio, contributing to its attractive valuation.
In the broader market context, GPT Healthcare's short-term performance stands in stark contrast to the Sensex, which has gained only 1.79% over the past month. While the stock has generated a return of 6.17% over the past year, its profits have risen by 5%, resulting in a PEG ratio of 6.4, indicating a reasonable valuation. The majority shareholders are promoters, which may instill confidence in the stock's stability. Overall, the combination of strong recent performance, efficient management, and favorable valuation metrics supports the stock's upward movement despite a slight decrease in trading volume.